Finance

Lists
ATRC:NASDAQ
AtriCure Inc
$56.84
+1.54%
(+0.86) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATRC...
Open
$56.11
High
$57.28
Low
$55.81
Mkt. cap
2.89B
Avg. vol.
814.22K
Volume
558.77K
P/E ratio
187.21
52-wk high
$66.02
52-wk low
$25.37
EPS
$0.30
Beta
1.23
Shares outstanding
50.92M
No. of employees
1K
Open
$56.11
High
$57.28
Low
$55.81
Mkt. cap
2.89B
Avg. vol.
814.22K
Volume
558.77K
P/E ratio
187.21
52-wk high
$66.02
52-wk low
$25.37
EPS
$0.30
Beta
1.23
Shares outstanding
50.92M
No. of employees
1K
News stories
From web sources and news partners
About AtriCure Inc
CEOMichael H Carrel | Michael H Carrel
Employees1.35K
FoundedNov 2000
HeadquartersMason, Ohio, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 8 analysts giving stock ratings to ATRC in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ATRC in the last 3 months.
Highest
Current $56.84
$70.00 (+23.15%)
Average
$66.00 (+16.12%)
Lowest
$57.00 (+0.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Maintained
$70.00
+23.2%
11/12/2026
Marie Thibault
BTIG
Buy
Reiterated
$70.00
+23.2%
11/03/2026
Lilia-Celine (Lily) Lozada
J.P. Morgan
Hold
Maintained
$62.00
+9.1%
11/04/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$70.00
+23.2%
11/04/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
$67.00
+17.9%
11/04/2026
Daniel Stauder
Citizens JMP
Buy
Maintained
$68.00
+19.6%
10/21/2026
Ryan Zimmerman
BTIG
Buy
Maintained
$63.00
+10.8%
10/12/2026
Keith Hinton
Freedom Capital Markets
Hold
Downgraded
$57.00
+0.3%
10/02/2026
Michael Matson
Needham
Buy
Reiterated
$64.00
+12.6%
09/02/2026
Priya Sachdeva
UBS
Buy
Reiterated
$50.00
-12%
07/28/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Danielle Antalffy
UBS
Buy
Maintained
$55.00
-3.2%
02/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
140.50M
141.25M
153.60M
154.45M
Cost of goods sold
35.16M
31.94M
34.98M
35.10M
Cost of revenue
35.16M
31.94M
34.98M
35.10M
Research and development expenses
24.50M
24.24M
26.40M
32.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
78.34M
84.55M
82.56M
82.88M
Operating expense
102.85M
108.78M
108.96M
115.00M
Total operating expenses
138.01M
140.72M
143.94M
150.10M
Operating income
2.49M
526.00K
9.66M
4.35M
Other non operating income
-641.00K
-37.00K
-100.00K
-123.00K
EBT including unusual items
2.36M
394.00K
9.43M
4.02M
EBT excluding unusual items
2.36M
394.00K
9.43M
4.02M
Income tax expense
604.00K
286.00K
471.00K
-47.00K
Effective tax rate
25.59%
72.59%
5.00%
-1.17%
Other operating expenses
-
-
-
-
Net income
1.76M
108.00K
8.96M
4.06M
Net profit margin
1.25%
0.08%
5.83%
2.63%
Earnings per share
0.06
-
0.18
0.17
Interest and investment income
1.33M
1.24M
1.18M
1.40M
Interest expense
-1.50M
-1.34M
-1.32M
-1.61M
Net interest expenses
-173.00K
-95.00K
-139.00K
-213.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
7.60M
5.80M
14.97M
9.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps